Biosimilars - On Demand Webinar

Join Jashin Wu, MD as he presents on biosimimlars: considerations for psoriatic diseases. Topics of this webinar include, the mechanism of action, routes of adminstration, and dosage of biosimilar drugs used in psoriatic disease, current legislation and FDA procedures related to biosimilar approvals and prescriptions, and how to identify manufacturing facility standards and procedures that contribute to variations among biosimilar drugs and biologies. 

To view the on-demand webinar for CME credit, please login and select Take Course at right.

If you do not yet have an account with the national psoriasis foundation, please click here to create a new account prior to taking this course. Thank you! 

 
Accreditation Statement

The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit

The National Psoriasis Foundation designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

Target Audience

Dermatologists, rheumatologists, primary care physicians, and allied health providers

Learning Objectives

  1. Describe the mechanism of action, routes of administration and dosage of biosimilar drugs used in psoriatic disease in relation to the reference products.
  2. Describe current legislation and FDA procedures related to biosimilar approvals and prescriptions, and implement tools and strategies when faced with interchangeability challenges from pharmacies or insurers, including notification, documentation and prevention.
  3. Identify manufacturing facility standards and procedures that contribute to variations among biosimilar drugs and biologics and articulate how these procedures create molecules that are similar to, but not replications of the original molecule, and how generic drugs differ from biosimilars.

Questions? Contact us at medevents@psoriasis.org or 503-546-8387

Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit™

    Accreditation

    This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education through the joint providership of Oregon Health & Science University (OHSU) and the National Psoriasis Foundation. OHSU is accredited by the ACCME to provide CME for physicians.

    Credit

    OHSU School of Medicine, Division of CME, designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 0.75 CE
Course opens: 
12/08/2016
Course expires: 
12/08/2018
Cost:
$0.00
Rating: 
0

Jashin J. Wu, MD
Founding Director of Dermatology Research
Director, Psoriasis Clinic
Department of Dermatology
Kaiser Permanente, Los Angeles Medical Center
Los Angeles, CA 


Disclosure link
 

Accreditation Period

Course opens: 
12/08/2016
Course expires: 
12/08/2018

Price

Cost:
$0.00
Please login to take this course.